Section 32 is a fund with a focus on biotech and healthcare startups. The fund was established by Bill Maris, the former founder and CEO of GV (fka Google Ventures).
2033 San Elijo Ave.
San Diego, 92007
California, United States
|2021-05-06||TwinStrand Biosciences||Series B||$50M||Alexandria Venture Investments, Janus Henderson Investors, Madrona Venture Group, Ridgeback Capital Management, Soleus Capital Management, and Undisclosed Investors|
|2021-04-22||Current Health||Series B||$43M||Element Ventures, LRVHealth, Northpond Ventures, OSF Ventures, and Undisclosed Investors|
|2021-04-15||C2i Genomics||Series B||$100M||Alexandria Real Estate Equities, Casdin Capital, Driehaus Capital Management, Duquesne Family Office, iGlobe Partners, Mark Foundation for Cancer Research, NFX, and Silver Lake|
|2021-04-14||Legacy||Series A||$10M||Bain Capital Ventures, FirstMark Capital, TQ Ventures, Tribe Capital, and Y Combinator|
|2021-03-23||Meatable||Series A||$47M||Agronomics, BlueYard Capital, DSM Venturing, Humboldt Fund, Jeffrey Leiden, Rick Klausner, and Taavet Hinrikus|